Skip to content

Combinostics at RSNA 2022

November 27-December 1, 2022  |  Chicago, IL
Booth: 3938 in the AI Showcase

Will you be at the RSNA 2022 Annual Meeting? Visit booth 3938 in the AI Showcase, or contact our team to schedule a meeting to learn more about our cloud-based platform supporting our AI solutions (cMRI™ and cDSI™), industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy.

Stop by and see the industry’s only neurological AI imaging and decision support solution spanning the entire patient care pathway for the early detection, diagnosis, and ongoing management of major neurological disorders

 Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

Our solutions put the focus on patients by providing objective, reliable insights for confident, evidence-based diagnostic and management decisions. Radiologists are better equipped to support referring clinicians and their patients with credible, validated imaging quantification and unique differential reporting for major neurological disorders.


MRI Only Differentiation of Dementias: AI-enabled Diagnostic Trend to Enable Differentiation of Dementias with Imaging Alone

November 28 at 11:30 – 11:45am CT in the AI Theatre

Schedule a meeting with our team.

Interested in a demo of our solutions and industry-leading diagnostic and clinically focused reports? Our team will be on the ground and ready to answer your questions.


Richard Hausmann

Chief Executive Officer (CEO)


Lennart Thurfjell

Chief Operating Officer (COO)


Greg Kingston

Chief Marketing Officer (CMO) 


 Thomas Gardner

Vice President US Sales


Chris Oppelt

US Sales Director – West


 Kristi Nucatola

US Sales Director – East


Luis Brenes

Clinical Application Specialist

Go beyond neurological image quantification.

For conditions such as dementia, multiple sclerosis, traumatic brain injury, and epilepsy, our platform supports earlier disease detection; faster, more efficient, differential diagnostic support; longitudinal tracking and prediction of disease progression; and detection and management of side effects.

Our AI solutions include:

  • cDSI
  • cMRI
  • cPET*
  • cARIA*

*WIP – not yet cleared for clinical use.


cDSI is an imaging AI tool that supports the entire patient care pathway for major neurological disorders, including detection, differentiation, and ongoing management.


cMRI is a neurological imaging tool that enables fully automated, objective quantification of disease-specific abnormalities and patterns from MRI images, including probabilities of specific diagnoses.
Differential Report

Dementia Differential Analysis report

The new Dementia Differential Analysis report is based on MRI data only, using our cDSI application’s proprietary machine learning method that measures the similarity of disease-specific imaging biomarker values from the patient to those from 2,000+ patients with a confirmed neurodegenerative disease.

It provides the probabilities of the following diagnoses for each patient:

  • Cognitively normal
  • Alzheimer’s disease
  • Frontotemporal dementia
  • Vascular dementia

Clinically focused cMRI reports

Our new clinically focused cMRI reports facilitate patient management as well as communication between radiologists, neurologists, patients, and their caregivers. These include reports for:
  • Dementia
  • Multiple sclerosis
  • Traumatic brain injuries
  • Epilepsy

 Will we see you at the 2022 RSNA Annual Meeting?